GreenLight Biosciences Holdings
GRNA · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $6 | $0 | $1 | $3 |
| % Growth | – | -100% | -67.9% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $6 | $0 | $1 | $3 |
| % Margin | 100% | – | 100% | 100% |
| R&D Expenses | $134 | $90 | $43 | $23 |
| G&A Expenses | $36 | $20 | $11 | $9 |
| SG&A Expenses | $36 | $20 | $11 | $9 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | -$2 | -$1 | $0 |
| Operating Expenses | $169 | $109 | $53 | $32 |
| Operating Income | -$164 | -$109 | -$52 | -$29 |
| % Margin | -2,567.7% | – | -5,434.9% | -973.1% |
| Other Income/Exp. Net | -$2 | -$4 | -$1 | $1 |
| Pre-Tax Income | -$166 | -$112 | -$53 | -$29 |
| Tax Expense | $1 | $2 | $1 | $0 |
| Net Income | -$167 | -$115 | -$54 | -$29 |
| % Margin | -2,616.8% | – | -5,642.3% | -965.2% |
| EPS | -1.27 | -0.93 | -0.56 | -0.3 |
| % Growth | -36.6% | -66.1% | -86.7% | – |
| EPS Diluted | -1.27 | -0.93 | -0.56 | -0.3 |
| Weighted Avg Shares Out | 132 | 123 | 96 | 96 |
| Weighted Avg Shares Out Dil | 132 | 123 | 96 | 96 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $0 | $0 | $1 |
| Interest Expense | $4 | $2 | $1 | $0 |
| Depreciation & Amortization | $10 | $6 | $2 | $2 |
| EBITDA | -$154 | -$103 | -$50 | -$28 |
| % Margin | -2,412.1% | – | -5,244% | -921.3% |